Urenco ChemPlants owns and will operate our most recent nuclear new build, Urenco’s Tails Management Facility.
Urenco ChemPlants Read moreSee what actions we are taking to achieve net zero by 2040 in our net zero transition plan.
Read it hereOur increased order book and solid financial and operational performance provide basis for future growth.
Read our latest report16 March 2024
On March 8, 2024, the Nuclear Regulatory Commission (NRC) accepted Urenco USA’s License Amendment Request (LAR) to increase enrichment levels from 5.5% to 10% (Low Enriched Uranium+ or LEU+). The NRC has agreed to review our request and expects to make a final decision by the end of 2024.
“This marks a positive milestone for Urenco USA and the industry. We remain dedicated to advancing sustainable energy by supporting this strategic effort to supply advanced fuels for current and future nuclear reactors,” stated Paul Lorskulsint, Chief Nuclear Officer and LEU+ Executive Sponsor.
About Urenco
Urenco is an international supplier of enrichment services and fuel cycle products with sustainability at the core of its business. Operating in a pivotal area of the nuclear fuel supply chain for 50 years, Urenco facilitates zero carbon electricity generation for consumers around the world.
With its head office near London, UK, Urenco’s global presence ensures diversity and security of supply for customers through enrichment facilities in Germany, the Netherlands, the UK and the USA. Using centrifuge technology designed and developed by Urenco, and through the expertise of our people, the Urenco Group provides safe, cost effective and reliable services; operating within a framework of high environmental, social and governance standards, complementing international safeguards.
Urenco is committed to continued investment in the responsible management of nuclear materials; innovation activities with clear sustainability benefits, such as nuclear medicine, industrial efficiency and research; and nurturing the next generation of scientists and engineers.
Media enquiries
Sign up to our newsletter by entering your email address below.